United States· US:69097-173_914605d4-7326-445d-b20e-6771eb67f7c4
Ipratropium Bromide and Albuterol Sulfate
A selective beta-2-adrenoreceptor agonists product containing ipratropium bromide and albuterol sulfate, registered in United States by Cipla USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Ipratropium Bromide and Albuterol Sulfate
- Manufacturer
- Cipla USA Inc.
- Country
- United States (US)
- ATC code
- R03AC
- ATC class
- Selective beta-2-adrenoreceptor agonists
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 2
- ndc1169097173536 POUCH in 1 CARTON (69097-173-53) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL
- ndc11690971736412 POUCH in 1 CARTON (69097-173-64) / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cce7a50e-04cd-43e4-92b7-0e20c4ac58d4 GET /v1/drugs/cce7a50e-04cd-43e4-92b7-0e20c4ac58d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "021SEF3731",
"rxcui": "142153",
"inchikey": "BNPSSFBOAGDEEL-UHFFFAOYSA-N",
"display_name": "ALBUTEROL SULFATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "RESPIRATORY (INHALATION)",
"spl_meta": {
"52c63e41-dbbc-d9d7-e063-6294a90a30c9": {
"match": "brand_token",
"title": "IPRATROPIUM BROMIDE SOLUTION [REDPHARM DRUG]",
"spl_version": "1",
"published_date": "2026-05-28"
}
},
"productid": "69097-173_914605d4-7326-445d-b20e-6771eb67f7c4",
"productndc": "69097-173",
"dosage_form": "SOLUTION",
"orange_book": {
"appl_no": "077559",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AN",
"strength": "EQ 0.083% BASE;0.017%",
"product_no": "001",
"approval_date": "Dec 31, 2007"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ALBUTEROL SULFATE; IPRATROPIUM BROMIDE",
"shortage_reason": "Albuterol Sulfate Solution",
"shortage_status": "current",
"proprietary_name": "Ipratropium Bromide and Albuterol Sulfate",
"active_ingred_unit": "mg/3mL; mg/3mL",
"application_number": "ANDA077559",
"marketing_category": "ANDA",
"nonproprietary_name": "Ipratropium Bromide and Albuterol Sulfate",
"start_marketing_date": "20071231",
"active_numerator_strength": "2.5; .5"
}See everything about ipratropium bromide and albuterol sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.